IDEC Board & Scientific Advisory Board
Board of Directors
William H. Rastetter, Ph.D.
Chairman, Chief Executive Officer and President, IDEC Pharmaceuticals Corporation
Charles C. Edwards, M.D.
Former President and CEO, Scripps Clinic and Research Foundation
Alan Burnett Glassberg, M.D.
Associate Director, University of California,
San Francisco Cancer Center; Director
Mount Zion Medical Center
Kazuhiro Hashimoto
President, Zenyaku Kogyo Co., Ltd.
Franklin P. Johnson, Jr.
General Partner, Asset Management Partners
Robert W. Pangia
Investment Banker
Bruce R. Ross
President, CancerRx
The Honorable Lynn Schenk
Lawyer, Former U.S. Congresswoman and Chief
of Staff to the Governor of California
William D. Young
Chairman of the Board and Chief Executive
Officer of ViroLogic, Inc.
Scientific/Clinical Advisory Board
James P. Allison, Ph.D.
Director, Cancer Research Laboratory; Professor of Immunology, Howard Hughes Medical Insitute Research Laboratories, University of California at Berkeley
Fred R. Appelbaum, M.D.
Director, Division of Clinical Research, Fred Hutchinson Cancer Research Center; Professor of Medicine, University of Washington
Jeffrey Bluestone, Ph.D.
Professor, Director, Ben May Institute for Cancer Research, Chicago, Illinois
Norman R. Klinman, M.D., Ph.D.
Professor of Immunology, Department of Immunology, Scripps Clinic and Research Foundation
Albert F. Lo Buglio
Director, Comprehensive Cancer Center, Evaline B. Spensor Professor of Oncology, Associate Dean for Research, School of Medicine, University of Alabama at Birmingham
Sherie L. Morrison, Ph.D.
Chairman and Professor, Department of Microbiology, Immunology and Molecular Genetics, University of California, Los Angeles
David Wofsy, Ph.D.
Professor of Medicine and Microbiology; Chief, Rheumatology/Immunology, Veterans Administration Medical Center, University of California, San Francisco